DeltaBev opened the world’s largest cannabis beverage facility located in Los Angeles, California.
As stated in a recent press release (1), DeltaBev has opened the world’s largest cannabis beverage manufacturing facility. The building is located in Los Angeles’s San Fernando Valley, California. DeltaBev began operations in January 2024 when CANN, the wunderkind brand, became their first production partner (1). The facility becomes the world’s largest cannabis beverage manufacturing facility through the capacity they are able to produce. It is 45,000 square feet and contains state-of-the-art processing and packaging qualities such as, “mini” production lines, canning, and bottling (1).
DeltaBev’s manufacturing facility follows quality standards for their beverage products and want to be known in the consumer-packaged goods (CPG) industry for high quality and as a trusted supplier (1). In their press release (1), the company mentioned that they, “prioritizes tetrahydrocannabinol (THC) potency preservation at all stages with reverse osmosis water filtration, water de-aeration, advanced mixing technologies, inline emulsion injection, CO2 purging, and counter pressure filling.” To stand out from other cannabis beverage competitors, DeltaBevs offers customers, standard procurement services. By offering this, the company hopes to create further competitive retail pricing which will provide more accessibility to consumers (1). “As part of the vertically integrated Blaze Life Holdings (BLH), the facility's production capabilities extend to seamless distribution with co-located SuLo Distro, a full-service cannabis distributor covering California,” as mentioned in the company’s press release (1).
“By streamlining our operations and eliminating unnecessary complexity, we are enabling downstream profitability and accelerating time to market, delivering fresher products to consumers faster,” Shreyas Balakrishnan, CEO of BLH, explained (1).
Mary Jones Soda specifically picked BLH to co-manufacture and distribute their products because of the company’s dedication to supply chain optimization (1). “We are excited about our next phase of growth in California and partnering with both DeltaBev and SuLo Distro. The Canoga Park facility accelerates our innovation into more beverage options as well as gummies and shots. The SuLo distribution capabilities will also ramp our go-to-market strategy as we expand our footprint into more California Dispensaries,” David Knight, CEO of Mary Jones, said (1).
“The cannabis beverage category is far from its tipping point, and we understand the power of full-scale efficiencies within the beverage distribution supply chain. While we cannot speculate exactly when regulations will be lifted, we are prepared for when they are,” Balakrishnan added (1).
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.